A RCT involving 80 patients with essential hypertension showed that combined with conventional western medicine treatment, tanshinone IIA could not only reduce SBP and DBP by 21 mmHg and 21 mmHg, respectively, but also reduce ET-1 and increase NO levels [140]. The gene discussed is EDN1; the disease is essential hypertension.